Skip to content

Clinical Trial on the Efficacy and Safety of a Water-in-Oil Single-Dose Essence Containing Recombinant Collagen

Clinical Trial on the Efficacy and Safety of a Water-in-Oil Single-Dose Essence Containing Recombinant Collagen

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125388
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-03-11
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early skin aging state

Interventions

test group:Use the single-dose essence in the morning and evening.

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Age 25-50 years old, healthy male or female; 2. Facial skin dullness score >=5 (on a 0-9 scale, 0=best, 9=worst); 3. Facial skin roughness score >= 5 (on a 0-9 scale, 0=best, 9=worst); 4. Project informed consent and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Skin diseases (such as psoriasis, eczema, psoriasis, skin cancer, etc.), or obvious wounds, abrasions, tattoos, etc., in or near the testing area; 3. Participated in similar tests within one month; 4. Participate in other clinical trial researchers; 5. Clinical assessment deemed unsuitable for trial participation;

Design outcomes

Primary

MeasureTime frame
Skin glossiness;Skin melanin;Skin roughness;

Secondary

MeasureTime frame
Loss rate of epidermal water diversion;Moisture content of skin stratum corneum;Safety assessment;Skin color;Skin elasticity;

Countries

China

Contacts

Public ContactXi Wang

West China Hospital of Sichuan University

xierwang@126.com+86 28 85422075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026